The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1497
ISSUE 1497
June 20, 2016
Issue 1497
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
A New Abuse-Deterrent Opioid - Xtampza ER
June 20, 2016 (Issue: 1497)
The FDA has approved Xtampza ER (Collegium),
a new extended-release, abuse-deterrent capsule
formulation of oxycodone, for management of pain
severe enough to require daily, around-the-clock,
long-term opioid treatment and for which...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.